-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Buy on Chemours, Lowers Price Target to $18

Benzinga·11/04/2026 16:54:01
Listen to the news
Truist Securities analyst Peter Osterland maintains Chemours (NYSE:CC) with a Buy and lowers the price target from $20 to $18.